| |
 |
Editorial [Hot Topic: Tyrosine Kinase Inhibitors in Cancer Therapy (Guest Editor: S. Eckhardt)]
 |
| |
|
pp.461-461 (1) Author: S. Eckhardt |
| |
|
|
| |
|
Antiangiogenic Drugs and Tyrosine Kinases
|
| |
|
pp.462-469 (8) Authors: Jozsef Timar, Balazs Dome |
| |
|
|
| |
|
Novel Molecular-Targeted Therapeutics for the Treatment of Cancer
|
| |
|
pp.470-480 (11) Authors: Hiroshi Yasui, Kohzoh Imai |
| |
|
|
| |
|
Inhibition of Receptor Tyrosine Kinases in Combination with Chemotherapy for the Treatment of Breast Cancer
|
| |
|
pp.481-487 (7) Authors: S. L. Moulder, B. S. Craft, G. N. Hortobagyi |
| |
|
|
| |
|
HER-2 Positive Breast Cancer: What Else Beyond Trastuzumab-Based Therapy?
|
| |
|
pp.488-496 (9) Authors: Christian Widakowich, Phuong Dinh, Evandro de Azambuja, Ahmad Awada, Martine Piccart-Gebhart |
| |
|
|
| |
|
New Trends in Molecular Imaging of Tumor Angiogenesis
|
| |
|
pp.497-522 (26) Authors: Thomas Berthelot, Marie-Claire Lasne, Gerard Deleris |
| |
|
|
| |
|
Monoclonal Antibodies in Clinical Oncology
|
| |
|
pp.523-532 (10) Authors: S. Dalle, C. Thieblemont, L. Thomas, C. Dumontet |
| |
|
|
| |
|
Targeting Inhibitor of Apoptosis Proteins (IAPs) for Cancer Therapy
|
| |
|
pp.533-539 (7) Author: Simone Fulda |
| |
|
|
| |
|
Bile Acids and Derivatives, Their Nuclear Receptors FXR, PXR and Ligands: Role in Health and Disease and Their Therapeutic Potential
|
| |
|
pp.540-563 (24) Authors: Amazia Zimber, Christian Gespach |
| |
|
|
| |
|
p53 Targeting Can Enhance Cancer Therapy via Radiation, Heat and Anti-Cancer Agents
|
| |
|
pp.564-570 (7) Authors: Takeo Ohnishi, Akihisa Takahashi, Eiichiro Mori, Ken Ohnishi |
| |
|
|
| |
|
Hyperthermia Associated Osteonecrosis in Young Patients with Pelvic Malignancies
|
| |
|
pp.571-575 (5) Authors: Marcus Jager, Stefan Balzer, Rudiger Wessalowski, J. Schaper, Ulrich Gobel, Xinning Li, Rudiger Krauspe |
| |
|
|
